EE9900510A - Leptiin kui tuumorirakkude proliferatsiooni inhibiitor - Google Patents

Leptiin kui tuumorirakkude proliferatsiooni inhibiitor

Info

Publication number
EE9900510A
EE9900510A EEP199900510A EEP9900510A EE9900510A EE 9900510 A EE9900510 A EE 9900510A EE P199900510 A EEP199900510 A EE P199900510A EE P9900510 A EEP9900510 A EE P9900510A EE 9900510 A EE9900510 A EE 9900510A
Authority
EE
Estonia
Prior art keywords
leptin
inhibitor
cell proliferation
tumor cell
tumor
Prior art date
Application number
EEP199900510A
Other languages
English (en)
Inventor
Barkan Dalit
Cohen Batya
Rubinstein Menachem
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9900510A publication Critical patent/EE9900510A/et
Publication of EE04801B1 publication Critical patent/EE04801B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2264Obesity-gene products, e.g. leptin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900510A 1997-04-29 1998-04-26 Leptiin kui tuumorirakkude proliferatsiooni inhibiitor EE04801B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12073397A IL120733A0 (en) 1997-04-29 1997-04-29 Leptin as an inhibitor of cell proliferation
PCT/IL1998/000196 WO1998048831A1 (en) 1997-04-29 1998-04-26 Leptin as an inhibitor of tumor cell proliferation

Publications (2)

Publication Number Publication Date
EE9900510A true EE9900510A (et) 2000-06-15
EE04801B1 EE04801B1 (et) 2007-04-16

Family

ID=11070075

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900510A EE04801B1 (et) 1997-04-29 1998-04-26 Leptiin kui tuumorirakkude proliferatsiooni inhibiitor

Country Status (25)

Country Link
US (1) US7109159B1 (et)
EP (1) EP0981365B1 (et)
JP (1) JP4330662B2 (et)
KR (1) KR100507731B1 (et)
CN (1) CN1168497C (et)
AR (1) AR012626A1 (et)
AT (1) ATE283702T1 (et)
AU (1) AU742927B2 (et)
BG (1) BG63490B1 (et)
CA (1) CA2288238A1 (et)
CZ (1) CZ299872B6 (et)
DE (1) DE69827942T2 (et)
EA (1) EA002353B1 (et)
EE (1) EE04801B1 (et)
ES (1) ES2232944T3 (et)
HU (1) HUP0002427A3 (et)
IL (2) IL120733A0 (et)
NO (1) NO322304B1 (et)
NZ (1) NZ500589A (et)
PL (1) PL195275B1 (et)
PT (1) PT981365E (et)
SK (1) SK284848B6 (et)
UA (1) UA66793C2 (et)
WO (1) WO1998048831A1 (et)
ZA (1) ZA983608B (et)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
IL132312A0 (en) * 1999-09-05 2001-03-19 Yeda Res & Dev Use of leptin in inhibition of endothelial cell proliferation
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
NZ579621A (en) 2004-02-11 2011-03-31 Amylin Pharmaceuticals Inc Hybrid polypeptides with selectable properties
US7863240B2 (en) * 2004-10-08 2011-01-04 Enzo Therapeutics, Inc. Methods and uses of leptin in hepatocellular carcinoma
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
KR20070115947A (ko) 2005-02-11 2007-12-06 아밀린 파마슈티칼스, 인크. 선택가능한 특성들을 가지는 gip 유사체 및 하이브리드폴리펩타이드
WO2007022123A2 (en) 2005-08-11 2007-02-22 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
EP2330125A3 (en) 2005-08-11 2012-12-12 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
US8716220B2 (en) * 2005-09-07 2014-05-06 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
MX344166B (es) * 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.
CA2725143A1 (en) * 2008-05-21 2009-11-26 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
TW202417497A (zh) 2015-10-12 2024-05-01 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
LT3538554T (lt) 2016-11-08 2025-10-10 Antigeną surišantys baltymai, antagonizuojantys leptino receptorius
SG11202005146VA (en) 2017-12-18 2020-06-29 Regeneron Pharma Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
PT3773713T (pt) 2018-04-06 2025-07-29 Regeneron Pharma Anticorpo agonista do recetor de leptina para usar no aumento da massa óssea num sujeito que sofre de disfunção metabólica ou de hipoleptinemia
CN120629571B (zh) * 2025-06-13 2026-03-27 蚌埠医学院第一附属医院(蚌埠医学院附属肿瘤医院) Lepr基因或蛋白作为靶标在制备胆管细胞癌治疗产品中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9802609A2 (hu) * 1995-06-30 1999-03-29 Eli Lilly And Co. A diabetes kezelésére szolgáló eljárás
EP0764722A2 (en) * 1995-09-19 1997-03-26 Eli Lilly And Company DNA encoding primate leptins as medicinal proteins
WO1997027286A1 (en) * 1996-01-23 1997-07-31 Progenitor, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development

Also Published As

Publication number Publication date
NO995267D0 (no) 1999-10-28
EE04801B1 (et) 2007-04-16
CA2288238A1 (en) 1998-11-05
CN1261802A (zh) 2000-08-02
UA66793C2 (uk) 2004-06-15
DE69827942T2 (de) 2005-12-08
SK284848B6 (sk) 2006-01-05
HUP0002427A2 (hu) 2000-12-28
PL336582A1 (en) 2000-07-03
ZA983608B (en) 1998-11-02
CZ384899A3 (cs) 2000-06-14
CN1168497C (zh) 2004-09-29
IL120733A0 (en) 1997-08-14
CZ299872B6 (cs) 2008-12-17
PT981365E (pt) 2005-03-31
WO1998048831A1 (en) 1998-11-05
PL195275B1 (pl) 2007-08-31
JP2001524968A (ja) 2001-12-04
BG63490B1 (bg) 2002-03-29
ATE283702T1 (de) 2004-12-15
AU742927B2 (en) 2002-01-17
JP4330662B2 (ja) 2009-09-16
EP0981365A1 (en) 2000-03-01
NO322304B1 (no) 2006-09-11
IL132633A (en) 2007-07-04
EA199900981A1 (ru) 2000-04-24
DE69827942D1 (de) 2005-01-05
KR100507731B1 (ko) 2005-08-10
KR20010012080A (ko) 2001-02-15
AR012626A1 (es) 2000-11-08
HUP0002427A3 (en) 2003-02-28
SK147199A3 (en) 2000-06-12
EA002353B1 (ru) 2002-04-25
NZ500589A (en) 2001-03-30
BG103832A (en) 2000-10-31
AU7076298A (en) 1998-11-24
HK1028350A1 (en) 2001-02-16
ES2232944T3 (es) 2005-06-01
EP0981365B1 (en) 2004-12-01
NO995267L (no) 1999-12-28
US7109159B1 (en) 2006-09-19

Similar Documents

Publication Publication Date Title
EE9900510A (et) Leptiin kui tuumorirakkude proliferatsiooni inhibiitor
EE200000706A (et) Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
EE9800351A (et) Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid
FI980038L (fi) Tuumorinekroositekijän alfa inhibiittoreita
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
DE19882069T1 (de) Voraussage logarithmischer Reduktionswerte
ID24612A (id) Hidrogenolisis gliserol
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
FI971935A7 (fi) Polyanioniset bentsyyliglykosidit sileän lihaskudoksen solujen lisääntymisen estäjinä
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DK1181269T3 (da) Celleproliferationsinhibitorer
DE69941468D1 (de) Zeitabgleichung von Aufwärtsverbindungs CDMA-Signalen
EP1108008A4 (en) NEW UBIQUITINE LIGASES USEFUL AS THERAPEUTIC TARGETS
FI971934A7 (fi) Asyloituja bentsyyliglykosideja sileälihassolulisääntymisen inhibiittoreina
EE03871B1 (et) Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid
FI971936A7 (fi) Sileän lihaskudoksen solujen lisääntymisen estäjät
IT240802Y1 (it) Struttura di dischetto levatrucco
ID17419A (id) Komposisi dekafluoropentana
IL132633A0 (en) Leptin as an inhibitor of tumor cell proliferation
SI0981365T1 (en) Leptin as an inhibitor of tumor cell proliferation
DK0981365T3 (da) Leptin som en inhibitor af tumorcelleproliferation
FI102727B1 (fi) Henkilökohtainen maadoitus
KR980005037U (ko) 복사방지 테이프의 강제 복사 회로
KR960038383U (ko) 전원공급장치의 과전력 보호회로

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20130426